Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712836 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Financial Markets Research: Bausch' returned 500 results - Page 1 of 26

  Sort by   
  Sorted by Rank Top-Bottom

Bausch & Lomb Incorporated - Product Pipeline Review - Q4 2010  
Global Markets Direct, Dec 2010, Pages: 72
and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Bausch & Lomb Incorporated - Brief company overview including business description, key information and facts


Bausch & Lomb Incorporated Market Share Analysis  
GlobalData, Sep 2011, Pages: 145
’s market position in the different medical equipment markets it operates in. The report provides Bausch & Lomb Incorporated market share information in four key market categories – Refractive Surgery Devices, Vitreo


Bausch & Lomb Incorporated - SWOT Analysis  
Datamonitor, Aug 2011, Pages: 28
,000 people. Bausch & Lomb is a private company and is not obliged to release its annual report. Therefore, financial details are not available for the company. Scope of the Report - Provides all the crucial


Bausch & Lomb Incorporated - Strategic SWOT Analysis Review  
GlobalData, Feb 2012, Pages: 48
Bausch & Lomb Incorporated - Strategic SWOT Analysis Review Summary Bausch & Lomb Incorporated (Bausch & Lomb) is an eye health company, engaged in manufacturing, developing and marketing vision


Opthalmic Pharmaceutical Drugs - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2010, Pages: 565
into Agreement 117 Bausch & Lomb Enters into Marketing Agreement with Novartis 117 Santen Pharmaceuticals and Ube Industries to Develop Glaucoma Therapy Jointly


Bausch & Lomb Incorporated-Therapeutic Competitors Report  
Life Science Analytics, March 2011, Pages: 210
Bausch & Lomb Incorporated-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all


IMS Company Profiles:Bausch & Lomb  
IMS Health, May 2011, Pages: 54
IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R


Argentina Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, Nov 2008, Pages: 67
Profile 45 13.1 Company Overview 45 13.2 Value Chain Analysis 46 13.2.1 Manufacturing 46 13.2.2 Product Development 46 13.2.3 Sales and Marketing 47 14 Bausch & Lomb Incorporated Company Profile 48 14


Analysis of the Allergan Inc.  
Aruvian's R'search, March 2011, Pages: 60
of the company, a geographical operating segments analysis, an analysis of the company’s major competitors namely Alcon, Bausch & Lomb, Johnson & Johnson, and Pfizer. A financial analysis of Allergan Inc


North America Ophthalmic Devices Market Outlook to 2016  
GlobalData, Nov 2010, Pages: 116
market. - Key players covered include Essilor International., Johnson & Johnson Vision Care, Inc, Bausch & Lomb Incorporated, Alcon, Inc CIBA Vision Corporation, Cooper Vision, Inc, Abbott Medical Optics, Inc


Bausch & Lomb Incorporated  
Datamonitor, Sep 2008, Pages: 26
and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Bausch & Lomb is engaged in the development, manufacture and marketing of eye health products, including


Canada Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, July 2008, Pages: 94
Trials 63 15 Bausch & Lomb Incorporated Company Profile 64 15.1 Company Overview 64 15.2 Value Chain Analysis 64 15.2.1 Manufacturing 65 15.2.2 Product Development 65 15.2.3 Sales and Marketing 66 15


Egypt Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, Nov 2008, Pages: 70
.2.1 Manufacturing 55 15.2.2 Product Development 55 15.2.3 Sales and Marketing 56 15.3 Bausch & Lomb Incorporated Pipeline Products 56 15.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type 56 15


Australia Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, July 2008, Pages: 105
and Marketing 84 17.3 Bausch & Lomb Incorporated Pipeline Products 85 17.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type 85 17.3.2 Bausch & Lomb Incorporated Pipeline Products by Development


Italy Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, July 2008, Pages: 96
by Clinical Trials 72 15 Bausch & Lomb Incorporated Company Profile 73 15.1 Company Overview 73 15.2 Value Chain Analysis 73 15.2.1 Manufacturing 74 15.2.2 Product Development 74 15.2.3 Sales and Marketing 75


Mexico Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, Nov 2008, Pages: 68
By News Summary 49 13 Bausch & Lomb Incorporated Company Profile 50 13.1 Company Overview 50 13.2 Value Chain Analysis 51 13.2.1 Manufacturing 51 13.2.2 Product Development 51 13.2.3 Sales and Marketing 53


South Africa Ophthalmic Devices, Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, Nov 2008, Pages: 69
.2.3 Sales and Marketing 49 12.3 Bausch & Lomb Incorporated Pipeline Products 49 12.3.1 Bausch & Lomb Incorporated Pipeline Products By Equipment Type 49 12.3.2 Bausch & Lomb Incorporated Pipeline Products


Belgium Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, Nov 2008, Pages: 86
Incorporated Company Profile 69 13.1 Company Overview 69 13.2 Value Chain Analysis 69 13.2.1 Manufacturing 70 13.2.2 Product Development 70 13.2.3 Sales and Marketing 71 13.3 Bausch & Lomb Incorporated Pipeline


Brazil Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, July 2008, Pages: 73
.2 Value Chain Analysis 60 16.2.1 Manufacturing 61 16.2.2 Product Development 61 16.2.3 Sales and Marketing 62 16.3 Bausch & Lomb Incorporated Pipeline Products 63 16.3.1 Bausch & Lomb Incorporated Pipeline


Spain Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012  
Global Markets Direct, July 2008, Pages: 84
Analysis 69 15.2.1 Manufacturing 70 15.2.2 Product Development 70 15.2.3 Sales and Marketing 71 15.3 Bausch & Lomb Incorporated Pipeline Products 72 15.3.1 Bausch & Lomb Incorporated Pipeline Products


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds